ARTV vs CLOV
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ARTV currently screens at market cap $37.3M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ARTV and CLOV stock pages for the full models.
Not investment advice.